Aclaris Therapeutics

Aclaris Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$5.48
Previous Close
$5.50
Day Range
$5.35-$5.52
52W Range
$1.46-$5.85
Market Cap
$779.3M
Shares Short
11M

Financials

See more
Revenue (12 Mos)
$8.3M
Revenue Growth (YoY)
37.2%
Gross Profit (12 Mos)
-$55.9M
Diluted EPS
-$0.56

News

See more

Yahoo Finance • 11 days ago

These low-priced stocks are flashing overbought signals

Yahoo Finance • last month

Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On

Yahoo Finance • 2 months ago

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

Yahoo Finance • 3 months ago

Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indication for ATI-2138, an Oral ITK/JAK3 Inhibitor

About

CEO
Dr. Neal S. Walker D.O., M.D.
Address
701 Lee Road, Wayne, PA, United States, 19087
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
69